Global Quetiapine Fumarate Competitive Landscape Professional Research Report 2025

Global Quetiapine Fumarate Competitive Landscape Professional Research Report 2025

Research Summary

Quetiapine fumarate is a medication belonging to the class of atypical antipsychotics. It is commonly prescribed under the brand name Seroquel. Quetiapine is used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder. The drug works by affecting the balance of neurotransmitters, particularly serotonin and dopamine, in the brain. It has antagonistic effects on certain receptors, which contribute to its therapeutic actions. Quetiapine is known for its efficacy in alleviating symptoms such as hallucinations, delusions, mood swings, and disturbances in thought patterns associated with psychiatric conditions. Additionally, it is sometimes used as an adjunct treatment for certain anxiety disorders. As with any medication, its use involves considerations of potential side effects, and patients are typically prescribed quetiapine under the supervision and guidance of healthcare professionals.

According to DIResearch's in-depth investigation and research, the global Quetiapine Fumarate market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Quetiapine Fumarate include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy＇s, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Quetiapine Fumarate. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Quetiapine Fumarate market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Quetiapine Fumarate market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Quetiapine Fumarate industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Quetiapine Fumarate Include:

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy＇s

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Quetiapine Fumarate Product Segment Include:

Immediate Release Tablets

Extended Release Tablets

Quetiapine Fumarate Product Application Include:

Schizophrenia

Bipolar Disorder

Major Depressive Disorder (MDD)

Generalized Anxiety Disorder (GAD)

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Quetiapine Fumarate Industry PESTEL Analysis

Chapter 3: Global Quetiapine Fumarate Industry Porter’s Five Forces Analysis

Chapter 4: Global Quetiapine Fumarate Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Quetiapine Fumarate Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Quetiapine Fumarate Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Quetiapine Fumarate Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources